Literature DB >> 6607919

Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.

E E Stobberingh, B I Davies, C P van Boven.   

Abstract

Twenty-eight strains of Branhamella catarrhalis, isolated from patients with acute exacerbations of chronic bronchitis, were tested both for beta-lactamase production and for sensitivity to a wide range of antimicrobial agents. A microtitre broth dilution technique was used for the latter and the MIC50, MIC90, and geometric mean MIC values were all calculated. Eleven strains were found to produce beta-lactamases. Isoelectric focusing in polyacrylamide gels showed four different band patterns, of which the most common was identical with that of the Ravasio type enzyme. Substrate profiles of the four types of branhamella beta-lactamases differed from each other although one was again similar to the Ravasio enzyme profile. Most of these beta-lactamases were readily inhibited by clavulanic acid (with I50 values of 0.01-0.08 mg/l) but were less readily inhibited by oxacillin. Attempts to isolate extrachromosomal DNA were unsuccessful. These results suggest that at least five possible different beta-lactamases can be demonstrated in Bran. catarrhalis strains, and that they are chromosomally determined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607919     DOI: 10.1093/jac/13.1.55

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Penetration of ampicillin and sulbactam in the lower airways during respiratory infections.

Authors:  Y J Valcke; M T Rosseel; R A Pauwels; M G Bogaert; M E Van der Straeten
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  [Moraxella catarrhalis: virulence and resistance mechanisms].

Authors:  W Cullmann
Journal:  Med Klin (Munich)       Date:  1997-03-15

3.  Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.

Authors:  E E Stobberingh; H J van Eck; A W Houben; C P van Boven
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors:  R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Purification and properties of a beta-lactamase produced by Branhamella catarrhalis.

Authors:  E Yokota; T Fujii; K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

6.  Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.

Authors:  I Luman; R W Wilson; R J Wallace; D R Nash
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.

Authors:  R J Fass; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

8.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 9.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  Branhamella catarrhalis respiratory infections in The Netherlands.

Authors:  F P Maesen; B I Davies
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.